1. Home
  2. Analysis
  3. Keppra
  4. Korlym

Keppra and Korlym drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Korlym (mifepristone). Common drug interactions include balance disorder among females and neoplasm malignant among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Korlym. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

On Jul, 10, 2026

18 people who take Keppra and Korlym together, and have interactions are studied.

Keppra and Korlym drug interactions.

What are the common drug interactions of Keppra and Korlym, by gender? *:

female:

  1. Balance disorder
  2. Blood cholesterol increased
  3. Blood glucose decreased
  4. Blood potassium decreased
  5. Decreased appetite
  6. Eye oedema (swelling or thickening of the macula, the area of the retina responsible for central vision)
  7. Fatigue (feeling of tiredness)
  8. Headache (pain in head)
  9. Hypotension (abnormally low blood pressure)
  10. Muscle atrophy (a decrease in the mass of the muscle)

male:

  1. Neoplasm malignant (cancer tumour)
  2. Death

What are the common drug interactions of Keppra and Korlym, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Diarrhoea
  2. Hypokalaemia (low potassium)
  3. Blood glucose decreased
  4. Decreased appetite
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Hypotension (abnormally low blood pressure)
  8. Muscle atrophy (a decrease in the mass of the muscle)
  9. Myalgia (muscle pain)
  10. Nausea (feeling of having an urge to vomit)

60+:

n/a

What are the existing conditions these people have? *

  1. Cushing's Syndrome (obesity, a rounded face, increased fat): 17 people, 94.44%
  2. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 11.11%
  3. Stress And Anxiety: 1 person, 5.56%
  4. High Blood Cholesterol: 1 person, 5.56%
  5. Gastrointestinal Stromal Tumor: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Korlym?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Keppra and Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Korlym and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and mifepristone (the active ingredients of Keppra and Korlym, respectively), and Keppra and Korlym (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.